Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Int J Infect Dis. 2010 Oct 18;14(12):e1088–e1092. doi: 10.1016/j.ijid.2010.08.002

Figure 1.

Figure 1

Prevalence of hematological abnormalities prior to initiation of antiretroviral therapy, by country. (A) Anemia, defined as a hemoglobin ≤10.0 g/dl. (B) Neutropenia, defined as an absolute neutrophil count ≤1.3 × 109/l. (C) Thrombocytopenia, defined as a platelet count less than 125 × 109/l.